A Novel Domain of the Inhibitory Glycine Receptor Determining Antagonist Efficacies: Further Evidence for Partial Agonism Resulting from Self-Inhibition-Reference-Cited by-同舟云学术

A Novel Domain of the Inhibitory Glycine Receptor Determining Antagonist Efficacies: Further Evidence for Partial Agonism Resulting from Self-Inhibition

Published:1999-09-01 Issue:3 Volume:56 Page:464-472
ISSN:0026-895X
Container-title:Molecular Pharmacology
language:en
Short-container-title:Mol Pharmacol

Author:

Schmieden Volker,Kuhse Jochen,Betz Heinrich

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmacology,Molecular Medicine

Reference31 articles.

1. Heterogeneity of Glycine Receptors and Their Messenger RNAs in Rat Brain and Spinal Cord

2. Nonlinear regression using spreadsheets

3. Differences in Agonist/Antagonist Binding Affinity and Receptor Transduction Using Recombinant Human γ-Aminobutyric Acid Type A Receptors

4. New insights into receptor theory, as provided by an artificial agonist made-to-measure.;Feuerstein;Naunyn-Schmiedeberg’s Arch Pharmacol,1994

5. Neuronal nicotinic receptors: Molecular organization and regulations

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Potential Metabolite Biomarkers of Multiple Sclerosis from Multiple Biofluids;ACS Chemical Neuroscience;2024-02-29

2. Thermophoretic analysis of ligand-specific conformational states of the inhibitory glycine receptor embedded in copolymer nanodiscs;Scientific Reports;2020-10-06

3. Fine-Tuning of Neuronal Ion Channels–Mapping of Residues Involved in Glucose Sensitivity of Recombinant Human Glycine Receptors;ACS Chemical Neuroscience;2020-10-02

4. Modulators of the Inhibitory Glycine Receptor;ACS Chemical Neuroscience;2020-05-11

5. Dihydropyrimidinase deficiency in four East Asian patients due to novel and rare DPYS mutations affecting protein structural integrity and catalytic activity;Molecular Genetics and Metabolism;2017-12